Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

Advisory Committees

-

Slides for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

FDA

FDA Core Presentations, Dabigatran Etexilate Mesylate Capsules, for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 1.1MB)

FDA Backup Presentations, Dabigatran Etexilate Mesylate Capsules, for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 61KB)

Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Core Presentations, Dabigatran Etexilate Mesylate Capsules, for the September 20, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (PDF – 8.2MB)

-

-